Welltower Inc., US95040Q1040

Barclays cuts Welltower target from USD 259 to USD 246 for Welltower stock

Published on 10/16/2026 at 09:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Second-quarter 2026 revenue rose 39.10 percent to USD 3.54 billion. Welltower stock costs EUR 209.25 on October 16, 2026 before October 26 results.

Targets and operating growth

  • Barclays cut its target from USD 259.00 to USD 246.00 on October 13, 2026.
  • Second-quarter 2026 revenue rose 39.10 percent to USD 3.54 billion.
  • Welltower stock trades at EUR 209.25 at 9:43 a.m. CEST at Lang & Schwarz on October 16, 2026.
Welltower Inc. (US95040Q1040) im Gesundheitssektor tätig, dargestellt als geometrisches Bauhaus-Poster mit Sektortext, Illustration mit AI erstellt.

Welltower Inc. (ISIN US95040Q1040) was the subject of a Barclays target cut from USD 259.00 to USD 246.00 on October 13, 2026, according to Markets Insider. At Lang & Schwarz, the stock was trading at EUR 209.25 on October 16, 2026 at 9:43 a.m. CEST. The lower target puts valuation discipline beside Welltower's strong operating growth.

Barclays lowers its target

Barclays kept an Equal Weight rating while reducing the target by USD 13.00. Markets Insider attributed the move to a third-quarter earnings preview, with senior housing fundamentals described as compelling and lodging comparisons expected to become tougher in 2027.

That contrast matters because Welltower is increasingly tied to operating performance rather than property ownership alone. The company describes itself as a healthcare real estate investment trust with more than 2,500 seniors and wellness housing communities across the United States, the United Kingdom and Canada, according to Welltower.

Three events changed the picture

On July 27, 2026, Welltower reported second-quarter revenue of USD 3.54 billion and diluted earnings per share of USD 0.61, according to MarketBeat. On September 16, 2026, it acquired Arcadia At Limerick Pointe for USD 40.60 million, as reported by Simply Wall St. Barclays then cut its target on October 13, 2026.

When are the next dates?

MarketBeat lists October 26, 2026 for Welltower's third-quarter results after the market close and October 27, 2026 at 9:00 a.m. ET for the conference call. Consensus calls for USD 3.66 billion in revenue and USD 0.6450 in earnings per share for the quarter.

Operating growth meets valuation pressure

For investors, the key tension is measurable: second-quarter revenue rose 39.10 percent year over year to USD 3.54 billion, while Barclays lowered its target by 5.02 percent from USD 259.00 to USD 246.00. The October 26 report will test whether operating momentum can support the valuation framework used by analysts. Welltower stock was trading at EUR 209.25 at Lang & Schwarz on October 16, 2026 at 9:43 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Welltower stock.

Welltower stock key data

  • Company: Welltower Inc.
  • ISIN: US95040Q1040
  • Ticker: WELL
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 16, 2026, 9:43 a.m. CEST): EUR 209.25
  • Sector / Industry: Real Estate / REIT - Healthcare Facilities
  • Index membership: S&P 500

Market context: Market report S&P 500.

More news and analyses on Welltower stock

Disclaimer...
en | US95040Q1040 | WELLTOWER INC. | boerse | 70337615 | bgmi